Parkinson’s Disease

Key Points

• Parkinson disease is a progressive movement disorder that can progress from mild unilateral symptoms to total ADL dependence.
• Core mechanism is dopamine depletion with relative acetylcholine excess in motor pathways.
• Cardinal motor features are resting tremor, rigidity, bradykinesia/akinesia, and postural instability.
• Autonomic and cognitive-behavioral symptoms can emerge as disease burden advances.

Pathophysiology

Parkinson disease reflects progressive dopaminergic neuron loss and decreased dopamine-mediated inhibition in motor-control pathways. As dopamine falls, relative cholinergic excitatory activity becomes functionally dominant, impairing coordinated voluntary movement.

Clinical motor symptoms usually become apparent after substantial dopamine depletion. Dopamine loss is also linked to autonomic changes such as orthostatic hypotension, drooling, and nocturia, which increase daily safety burden.

Clinical Manifestations

• Resting tremor: Most common initial complaint; decreases with purposeful movement and may present as classic pill-rolling.
• Rigidity: Increased resistance to passive movement, often cogwheel quality, progressing to generalized stiffness and limited ADL function.
• Bradykinesia/Akinesia: Slowed or absent voluntary movement initiation, including difficulty rising from seated position.
• Postural instability and gait change: Forward-flexed posture with propulsive shuffling gait and high fall risk.

Progressive facial and bulbar muscle involvement can produce mask-like facies, dysarthria, swallowing difficulty, and aspiration/malnutrition risk. Later disease may also include psychosis or dementia-spectrum cognitive decline.

Classification

• Stage 1 (Initial): Unilateral limb involvement with mild tremor/weakness.
• Stage 2 (Mild): Bilateral involvement with resting tremor, bradykinesia, and mask-like facial expression.
• Stage 3 (Moderate): Postural instability, gait irregularity, and pill-rolling tremor.
• Stage 4 (Severe): Marked akinesia and rigidity with major functional impairment.
• Stage 5 (Total Dependence): Near-complete caregiver dependence for ADLs.

Nursing Assessment

NCLEX Focus

Distinguish chronic baseline parkinsonian findings from sudden new focal deficits that may indicate a separate acute neurologic emergency.

• Assess gradual progression pattern, symptom burden, and current stage-related functional limits.
• Assess cardinal symptoms: resting tremor, rigidity, bradykinesia/akinesia, and postural instability.
• Assess fall risk, transfer safety, and ADL dependence trend over time.
• Report changes in strength, gait, mobility, or cognition because these often indicate meaningful functional decline.
• Assess for autonomic symptoms (orthostasis, drooling, nocturia) and evolving cognitive/behavioral changes.
• Assess speech-volume change, swallowing safety, and aspiration warning signs as rigidity progresses.
• Assess for constipation, urinary retention, sexual dysfunction, sleep disturbance, depression, hallucinations, and impaired judgment/decision-making.
• Prioritize common nursing-diagnosis domains: impaired mobility, swallowing difficulty, confusion/memory change, communication impairment, fall risk, activity intolerance, and constipation.

Diagnostic Approach

There is no single confirmatory test for Parkinson disease. Diagnosis is primarily clinical and supported when at least two cardinal motor findings are present. Additional testing is used to exclude alternative neurologic causes:

• Blood tests to evaluate non-parkinsonian causes of symptoms.
• SPECT in selected contexts to identify reduced dopamine-producing neuron activity.
• CSF analysis that may show dopamine reduction patterns.
• CT/MRI to rule out other structural neurologic disorders.

Nursing Interventions

• Use a mobility and fall-prevention plan matched to current stage and gait instability.
• Keep assistive devices within reach and allow additional time to complete ADLs safely.
• Preserve independence by allowing extra time for ADLs while providing targeted assistive support.
• Coordinate early access to movement-disorder expertise and rehabilitation services when available.
• Address health-equity barriers that limit access to specialty, rehabilitation, and mental-health care.
• Reevaluate care goals over time for mobility, aspiration prevention, communication effectiveness, bowel function, and safety outcomes.
• Collaborate with PT/OT for ROM/stretching/activity plans, assistive-device training, and adaptive equipment to preserve ADL participation.
• Collaborate with SLP for dysarthria and dysphagia support, including swallow-muscle exercise and alternate communication modalities.
• When medication response declines, anticipate advanced-management discussions (for example stereotactic pallidotomy or deep-brain stimulation) and reinforce postoperative monitoring plans.
• Administer PD medications on schedule to maintain therapeutic consistency and monitor for orthostatic hypotension, confusion, and hallucinations.
• Implement immobility-prevention measures (pressure-injury prevention, bowel plan, contracture prevention) while preserving autonomy.
• Time activities for peak-function periods (often later morning) to reduce rushing and fatigue.
• Coordinate dietician input for dysphagia diets (for example soft foods/thickened liquids), nutrition supplements, and constipation-focused diet adjustments.

Expected Outcomes

• Client remains free from serious fall or immobility complications.
• Nutrition and hydration remain adequate while aspiration events are prevented.
• Communication strategies are sufficient for care needs.
• Client and caregivers can describe symptom-management and coping strategies.

Health Teaching and Care Transitions

• Teach safe medication administration and early reporting of acute confusion, hallucinations, and severe orthostatic symptoms.
• Teach household fall-risk reduction (remove clutter/rugs, use assistive devices correctly).
• Reinforce symptom-management routines: fluids/fiber for constipation, sleep-hygiene habits, and strength-focused coping.
• Encourage caregiver use of support groups and Parkinson-specific community organizations.
• Engage case-management/social-work support for psychosocial planning, insurance/financial navigation, respite planning, and potential long-term-care transition.

Evaluation

Outcome evaluation is continuous and should be repeated at each reassessment, major diagnostic/laboratory update, and interdisciplinary/family care review. If outcomes are partially met or unmet, revise and reimplement the care plan.

Complication Risk

Progressing rigidity, gait disturbance, and swallowing decline increase risk for falls, aspiration, malnutrition, and caregiver strain.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
dopaminergic-therapy	Carbidopa/levodopa, dopamine agonist contexts	Monitor for symptom fluctuation, dyskinesia, orthostasis, and neuropsychiatric adverse effects.
MAO-B/MAOI contexts	Selegiline, rasagiline	Reinforce tyramine precautions and monitor for hypertensive or adverse neurologic effects.
Anticholinergic contexts	Benztropine, trihexyphenidyl	Monitor older adults for poor tolerance, urinary retention (especially with BPH), and increased intraocular-pressure risk.
COMT inhibitor contexts	Entacapone, tolcapone	Used with carbidopa/levodopa to prolong benefit duration; monitor response and adverse effects.

Levodopa-based regimens are most effective early in disease but may lose duration over time. Long-term treatment (often after 5-10 years) can produce dyskinesia and tolerance patterns requiring dose/frequency adjustment, regimen change, or closely monitored medication interruption in selected cases.

Clinical Judgment Application

Clinical Scenario

An older adult with Parkinson disease reports worsening shuffling gait, rising near-falls, and new dependence for dressing.

• Recognize Cues: Progressing motor dysfunction with increasing injury risk.
• Analyze Cues: Stage progression is reducing safe mobility and ADL capacity.
• Prioritize Hypotheses: Immediate safety stabilization and fall-risk reduction are priority.
• Generate Solutions: Strengthen transfer supervision, optimize assistive devices, and coordinate interdisciplinary reassessment.
• Take Action: Implement fall precautions and communicate functional decline to the care team.
• Evaluate Outcomes: Near-falls decrease and ADL plan is adjusted to preserve function.

Related Concepts

• neurological-system - Dopamine-pathway dysfunction in movement control.
• dopaminergic-therapy - Medication strategies for symptom control.
• common-neurological-disorders-recognition-and-priority-care - Pattern recognition and escalation context.
• fall-prevention - High-priority safety framework for gait and postural instability.
• caregiver-role-strain - Progressive dependence increases family-care burden.

Self-Check

1. Which clinical findings indicate Parkinson progression rather than an acute stroke pattern?
2. Why does dopamine depletion produce both motor and autonomic manifestations?
3. Which care priorities best reduce injury as ADL dependence increases?